NCT06020586 is a NA clinical trial of hair lotion in Chemotherapy-induced Alopecia, sponsored by Instituto de Oncología Ángel H. Roffo.

Who is sponsoring NCT06020586?

NCT06020586 is sponsored by Instituto de Oncología Ángel H. Roffo.

What drugs are being tested in NCT06020586?

Interventions in NCT06020586: hair lotion.

What condition does NCT06020586 study?

NCT06020586 studies Chemotherapy-induced Alopecia.

Is NCT06020586 still recruiting?

NCT06020586 is currently status unknown. Last updated 31 August 2023.

Last reviewed 2023-08-31 · How we verify

NCT06020586

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study To Evaluate The Efficacy And Safety Profile of ECOHAIR in Chemo-induced Alopecia.

Status unknown NA Last updated 31 August 2023

What this trial tests

NA trial testing hair lotion in Chemotherapy-induced Alopecia in 22 participants. Status unknown.

Timeline

6 June 2022

Primary endpoint
1 November 2023

30 December 2023

Quick facts

Lead sponsor	Instituto de Oncología Ángel H. Roffo
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	6 June 2022
Primary completion	1 November 2023
Estimated completion	30 December 2023
Sites	1 location across Argentina

Drugs / interventions tested

hair lotion

Conditions studied

Chemotherapy-induced Alopecia — all drugs for Chemotherapy-induced Alopecia →

Sponsor

Instituto de Oncología Ángel H. Roffo

Who can join

Adults 18 to 65, female only, with Chemotherapy-induced Alopecia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a Phase 2, single-center study designed to determine the effect of ECOHAIR topical solution on scalp hair growth evaluated objectively ( images) and subjectively ( patient and investigator reports). A total of 22 subjects are planned to be enrolled, 15 in a prospective single-arm phase in which they will receive the study treatment and 7 controls. Patients should have a clinical diagnosis of chemotherapy-induced alopecia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chemotherapy-induced Alopecia

Currently open trials in the same condition.

NCT05484973 — Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss · NA · recruiting
NCT06215469 — Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) · NA · recruiting
NCT06011525 — Prevention of Alopecia in Patients With Localised Breast Cancer · NA · recruiting
NCT04986579 — Scalp Cooling in MBC · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06020586 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto de Oncología Ángel H. Roffo
Last refreshed: 31 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06020586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing